Ons wil graag hê dat jy deel word van ons gemeenskap. Sluit aan by ons Discord om met ons en ander lede te skakel!

Ticker
ACT.F

Price
57.00
Stock movement down
-1.40 (-2.40%)
Company name
AlzChem Group AG
Exchange
(F
,
Currency
EUR
)
Sector
Basic Materials >
Specialty Chemicals
Markkapitalisasie
580.05M
Ondernemingswaarde
814.86M
Prys/Verkope
1.05
Prys/Boek
3.18
Dividendopbrengs
-
Dividendgroei
-
Groei jare
-
FCF uitbetaling
13.40%
Agterlopende P/E
12.52
Volgende P/E
10.45
PEG
-
EPS groei
8.86%
1 jaar opbrengs
115.91%
3 jaar opbrengs
35.33%
5 jaar opbrengs
21.64%
10 jaar opbrengs
12.80%
Laaste opgedateer: 2024-12-21

DIVIDENDE

ACT.F betaal nie dividende nie of geen data is ontvang nie

WAARDERING

Waarderingsverhoudings

Loading...
Waarderingsverhoudings gegewens
Agterlopende P/E12.52
Prys tot OCF6.00
Prys tot FCF6.36
Prys tot EBITDA29.69
EV tot EBITDA41.71

Waardering (Verkope/Boekwaarde)

Loading...
Waardering (Verkope/Boekwaarde) gegewens
Prys tot verkope1.05
Prys tot Boekwaarde3.18
EV tot verkope1.48

FINANSIËLE

Per aandeel

Loading...
Per aandeel gegewens
Huidige aandeeltelling10.18M
EPS (TTM)4.55
FCF per aandeel (TTM)8.96

Inkomstestaat

Loading...
Inkomstestaat gegewens
Inkomste (TTM)549.87M
Bruto wins (TTM)350.69M
Bedryfsinkomste (TTM)71.47M
Netto inkomste (TTM)46.34M
EPS (TTM)4.55
EPS (1j vorentoe)5.46

Marges

Loading...
Marges gegewens
Bruto marge (TTM)63.78%
Bedryfsmarge (TTM)13.00%
Winsgrens (TTM)8.43%

Balansstaat

Loading...
Skep asseblief 'n gratis rekening of meld aan om toegang tot hierdie grafiek te kry
Balansstaat gegewens
Kontant46.07M
Netto debiteure76.88M
Totale bedryfsbates255.93M
Klandisiewaarde0.00
Ontasbare bates8.09M
Eiendom, aanleg en toerusting0.00
Totale bates463.43M
Rekeninge betaalbaar51.47M
Kort/huidige langtermynskuld0.00
Totale bedryfslaste109.94M
Totale laste280.87M
Aandeelhouersbelang182.55M
Netto tasbare bates0.00

Kontantvloei

Loading...
Skep asseblief 'n gratis rekening of meld aan om toegang tot hierdie grafiek te kry
Kontantvloei gegewens
Bedryfskontantvloei (TTM)96.69M
Kapitale uitgawes (TTM)5.54M
Vrye kontantvloei (TTM)91.14M
Dividende betaal (TTM)12.21M

Finansiële opbrengste

Loading...
Skep asseblief 'n gratis rekening of meld aan om toegang tot hierdie grafiek te kry
Finansiële opbrengste gegewens
Opbrengs op ekwiteit25.38%
Opbrengs op bates10.00%
Opbrengs op belegde kapitaal20.43%
Kontant opbrengs op belegde kapitaal40.19%

AANDELE INLIGTING

Aandele grafiek

Loading...
Aandele prys data
Open57.00
Daaglikse hoog57.00
Daaglikse laag57.00
Daaglikse volume0K
Hoogtepunt van alle tye3209699.62
1j analiseraaming74.17
Beta0.95
EPS (TTM)4.55
Dividend per aandeel-
Ex-dividend datum8 May 2024
Volgende verdienste datum27 Feb 2025

Afwaartse potensiaal

Loading...
Afwaartse potensiaal gegewens
ACT.FS&P500
Huidige prysdaling vanaf die hoogste punt van alle tye-100.00%-3.57%
Hoogste prysdaling-100.00%-56.47%
Datum van hoogste daling5 Aug 20049 Mar 2009
Gemiddelde daling vanaf hoogtepunt-97.56%-11.13%
Gemiddelde tyd tot nuwe hoogtepunt1276 days12 days
Maksimum tyd tot nuwe hoogtepunt6356 days1805 days
MAATSKAPPY BESONDERHEDE
ACT.F (AlzChem Group AG) company logo
Markkapitalisasie
580.05M
Markkapitalisasie kategorie
Small-cap
Beskrywing
AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand. It also provides fine and specialty chemicals, including products based on calcium carbide, calcium cyanamide, hydrogen cyanamide, dicyandiamide, guanidine, guanamines, and nitroguanidine, as well as aromatic and aliphatic nitriles; calcium cyanamide under the PERLKA name; germicide for use in pig pens under the ALZOGUR name; plant growth regulators under the Dormex and Sitofex name; and plant protection additives under the BREAK-THRU name. In addition, the company offers products for use in hot metal desulfurization and secondary metallurgy applications; and technical gases. Further, it provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. The company was founded in 1908 and is based in Trostberg, Germany.
Werknemers
1506
Beleggerverhoudings
-
CEO
Land
Germany
Stad
Aandele tipe
-
CCC status
-
Dividendfrekwensie
-
GEBEURE EN AANBIEDINGS
GebeureAanbiedings
Loading...
VERSTAAN DIE BESIGHEID
Loading...
MAATSKAPPY NUUS
Alle nuusPersvrystellings
While AlzChem Group AG ( ETR:ACT ) might not have the largest market cap around , it saw a significant share price rise...
15 Desember 2024
Key Insights Given the large stake in the stock by institutions, AlzChem Group's stock price might be vulnerable to...
28 November 2024
AlzChem Group ( ETR:ACT ) Third Quarter 2024 Results Key Financial Results Revenue: €132.7m (up 7.0% from 3Q 2023). Net...
12 November 2024
AlzChem Group's (ETR:ACT) stock is up by a considerable 26% over the past month. Given that the market rewards strong...
30 Oktober 2024
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...
3 Oktober 2024
Key Insights Using the 2 Stage Free Cash Flow to Equity, AlzChem Group fair value estimate is €38.37 With €40.80 share...
19 September 2024
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if...
2 September 2024
AlzChem Group AG ( ETR:ACT ) just reported healthy earnings but the stock price didn't move much. Our analysis suggests...
9 Augustus 2024
AlzChem Group ( ETR:ACT ) Second Quarter 2024 Results Key Financial Results Revenue: €139.9m (up 5.2% from 2Q 2023...
3 Augustus 2024
AlzChem Group AG ( ETR:ACT ), is not the largest company out there, but it saw a significant share price rise of 45% in...
25 Junie 2024
Volgende bladsy